Clinical Trial Results:
The efficacy and safety of two doses of strontium ranelate (1g and 2g per day) versus placebo administered orally for 3 years in the treatment of knee osteoarthritis. A prospective multicentre, international, double-blind, placebo-controlled study.
Summary
|
|
EudraCT number |
2005-002494-75 |
Trial protocol |
DE AT BE GB ES IT DK PT LT EE CZ |
Global completion date |
17 Feb 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
10 Dec 2016
|
First version publication date |
10 Dec 2016
|
Other versions |
|
Summary report(s) |
Synopsis dated on 20-March-2012 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.